about
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review.Morbidity of pandemic H1N1 influenza in children with cancer.Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.Local control in metastatic neuroblastoma in children over 1 year of ageMicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.Congenital glioblastoma.Current evidence of antifungal prophylaxis and therapy in pediatric patients.Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).Acquired amnesia in childhood: a single case study.Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.Immunoselection techniques in hematopoietic stem cell transplantation.Pediatric nonrhabdomyosarcoma soft tissue sarcomas arising at visceral sites.Nano-Delivery In Pediatric Tumors: Looking Back, Moving Forward.Winners' Cup: a national football tournament brings together adolescent patients with cancer from all over Italy.A survey on hematology-oncology pediatric AIEOP centers: prophylaxis, empirical therapy and nursing prevention procedures of infectious complications.Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's Hospital.Neurovesical dysfunction in children after treating pelvic neoplasms.A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.Detection and clinical significance of disseminated tumour cells at diagnosis in bone marrow of children with localised rhabdomyosarcoma.Prolonged response to oral gefitinib, cyclophosphamide, and topotecan in heavily pretreated relapsed stage 4 neuroblastoma: a case report.High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital eEvaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.Src nuclear localization and its prognostic relevance in human osteosarcoma.Intraspinal mesenchymal chondrosarcoma: report of a pediatric case and literature review.Salvage rates and prognostic factors after relapse in children and adolescents with malignant peripheral nerve sheath tumors.Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.Biliary tract rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Associazione Italiana Ematologia Oncologia Pediatrica.Radiological classification of optic pathway gliomas: experience of a modified functional classification system.Congenital Rhabdomyosarcoma: a different clinical presentation in two cases.Precision diagnostics of Ewing's sarcoma by liquid biopsy: circulating EWS-FLI1 fusion transcripts.Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.Denosumab in patients with aneurysmal bone cysts: A case series with preliminary resultsTopotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma CommitteeFusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Retrospective survey on the off-label use of posaconazole in pediatric hematology patientsHemangioendothelioma: successful therapy with interferon-alpha: a study in Association with the Italian Pediatric Haematology/Oncology Society (AIEOP)Expression profiles of exosomal miRNAs isolated from plasma of patients with desmoplastic small round cell tumor
P50
Q30240183-5E1AC189-E0AD-4739-BFFA-FF07A372190AQ30240212-6838EEAD-5635-4B99-BEC5-9DEB00425EC8Q30240229-9631F378-912C-4D42-B8E3-D31C9A84C07BQ30390789-33A8396B-14FB-4843-A62B-FCC27CFDA8D6Q33567866-FC56A742-9C1C-42C2-98F4-87C0947E9C30Q35146875-B72AF893-8F58-4880-B611-6D07DC5DE531Q35922940-2275719F-7248-41E6-83C1-DE115924B67FQ37421886-01A5A31C-3932-4802-9DEA-323C1B11DCA0Q37885746-F96A8866-DE6D-4FFF-A6AC-68E04905A0C7Q38208101-16F298E6-DF03-45EB-A4EA-2954E3832CD5Q38403583-B068A9B2-55C5-4487-9C30-F5DD8401449DQ38739856-B250794D-3849-49C5-9215-65A8459ADC13Q38840989-508F33D2-EE54-4539-BA98-96E1A795E935Q38944581-414386E4-50D4-4827-AC37-31F8A3A90BA1Q39065456-E6D98337-D072-4833-9BB5-B33EB1FCF361Q40139867-92F21DFE-8937-4647-8ED1-DB3B4167F4E2Q41971493-F768EDF8-76DE-422D-B911-2895CF14E70EQ42240047-762E3CEE-3499-473A-8FED-EC50BE628DB0Q43185074-EFEA14EF-4631-4D05-895E-86159EFBC75CQ43364783-931F66E6-2BD5-40D6-B3FB-E940C941FB82Q44192137-7741A703-D67D-4DB4-9231-3C4DEBC109ECQ44587881-F90881FD-027C-4F12-BB4D-82B5847AB0F1Q46913170-6BBFC52E-8EFF-4F9B-B64B-48123F998F5EQ46987541-D922A24B-6A07-4CCB-BB2F-9AE7D33192A4Q47229175-6FD70D2A-6097-4D3A-837D-9517FB916615Q47965081-072FDD5F-3323-4419-BFC1-63C1F99C0850Q47967036-1E07021E-C36E-45FD-8FD9-70EB330D8A30Q48322618-899A55C3-A683-4FA5-BACB-59C12671D178Q48344679-261F97AF-ECEF-48A8-B4BD-837BC33F850BQ52742234-0CF5FE7A-FF9F-4F64-A0F5-A527C058953DQ53208551-6099204A-C5C1-4332-B117-6D283092AE3CQ55039629-2ABAE5D1-7B20-4D8C-81E2-CEE1BA88FE88Q55083783-480C90E7-0F6F-407D-A044-785F4F743170Q55463966-9345D250-C700-4A6A-9494-F189EA138400Q56346763-EFF34282-945B-4B8D-AC54-9C15EC5F9A5CQ57168156-E43BA43A-7812-4B5B-88A7-B478DC110FD5Q58486098-B0811585-1706-4F3E-9DA1-BFB7352C6BF5Q60210851-506BEFC2-8DE8-465E-811C-C9B56D2797DDQ77551184-EAF7CFFB-5F55-41EF-AC3F-E5C3BC92E3DBQ90658499-4A0EEFE3-3951-4C4E-8B66-AA808EF70A34
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giuseppe Maria Milano
@ast
Giuseppe Maria Milano
@en
Giuseppe Maria Milano
@es
Giuseppe Maria Milano
@nl
type
label
Giuseppe Maria Milano
@ast
Giuseppe Maria Milano
@en
Giuseppe Maria Milano
@es
Giuseppe Maria Milano
@nl
altLabel
giuseppe maria milano
@en
prefLabel
Giuseppe Maria Milano
@ast
Giuseppe Maria Milano
@en
Giuseppe Maria Milano
@es
Giuseppe Maria Milano
@nl
P106
P21
P31
P496
0000-0002-0250-6043